FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation

Summary: Transcriptional regulatory mechanisms of lineage priming in embryonic development are largely uncharacterized because of the difficulty of isolating transient progenitor populations. Directed differentiation of human pluripotent stem cells (hPSCs) combined with gene editing provides a power...

Full description

Bibliographic Details
Main Authors: Kihyun Lee, Hyunwoo Cho, Robert W. Rickert, Qing V. Li, Julian Pulecio, Christina S. Leslie, Danwei Huangfu
Format: Article
Language:English
Published: Elsevier 2019-07-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124719308009
_version_ 1818947583090884608
author Kihyun Lee
Hyunwoo Cho
Robert W. Rickert
Qing V. Li
Julian Pulecio
Christina S. Leslie
Danwei Huangfu
author_facet Kihyun Lee
Hyunwoo Cho
Robert W. Rickert
Qing V. Li
Julian Pulecio
Christina S. Leslie
Danwei Huangfu
author_sort Kihyun Lee
collection DOAJ
description Summary: Transcriptional regulatory mechanisms of lineage priming in embryonic development are largely uncharacterized because of the difficulty of isolating transient progenitor populations. Directed differentiation of human pluripotent stem cells (hPSCs) combined with gene editing provides a powerful system to define precise temporal gene requirements for progressive chromatin changes during cell fate transitions. Here, we map the dynamic chromatin landscape associated with sequential stages of pancreatic differentiation from hPSCs. Our analysis of chromatin accessibility dynamics led us to uncover a requirement for FOXA2, known as a pioneer factor, in human pancreas specification not previously shown from mouse knockout studies. FOXA2 knockout hPSCs formed reduced numbers of pancreatic progenitors accompanied by impaired recruitment of GATA6 to pancreatic enhancers. Furthermore, FOXA2 is required for proper chromatin remodeling and H3K4me1 deposition during enhancer priming. This work highlights the power of combining hPSC differentiation, genome editing, and computational genomics for discovering transcriptional mechanisms during development. : Lee et al. use ATAC-seq to identify key transcriptional factors involved in human pancreatic differentiation. FOXA2 knockout human pluripotent stem cells showed impaired differentiation to pancreatic progenitors, a phenotype not observed in Foxa2 conditional knockout mice. Furthermore, FOXA2 is required for proper chromatin remodeling and H3K4me1 deposition during enhancer priming. Keywords: human pluripotent stem cells, hPSCs, human embryonic stem cells, hESCs, pancreatic progenitors, ATAC-seq and chromatin accessibility, FOXA2, FOXA1, enhancer priming and activation, nucleosome remodeling, PDX1, GATA6
first_indexed 2024-12-20T08:33:12Z
format Article
id doaj.art-3ae9bdac9b504487a47ec8680a20e805
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-20T08:33:12Z
publishDate 2019-07-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-3ae9bdac9b504487a47ec8680a20e8052022-12-21T19:46:38ZengElsevierCell Reports2211-12472019-07-01282382393.e7FOXA2 Is Required for Enhancer Priming during Pancreatic DifferentiationKihyun Lee0Hyunwoo Cho1Robert W. Rickert2Qing V. Li3Julian Pulecio4Christina S. Leslie5Danwei Huangfu6Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Graduate School of Medical Sciences at Cornell University, New York, NY 10065, USAWeill Graduate School of Medical Sciences at Cornell University, New York, NY 10065, USA; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USADevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USADevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USADevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USAComputational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Corresponding authorDevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Corresponding authorSummary: Transcriptional regulatory mechanisms of lineage priming in embryonic development are largely uncharacterized because of the difficulty of isolating transient progenitor populations. Directed differentiation of human pluripotent stem cells (hPSCs) combined with gene editing provides a powerful system to define precise temporal gene requirements for progressive chromatin changes during cell fate transitions. Here, we map the dynamic chromatin landscape associated with sequential stages of pancreatic differentiation from hPSCs. Our analysis of chromatin accessibility dynamics led us to uncover a requirement for FOXA2, known as a pioneer factor, in human pancreas specification not previously shown from mouse knockout studies. FOXA2 knockout hPSCs formed reduced numbers of pancreatic progenitors accompanied by impaired recruitment of GATA6 to pancreatic enhancers. Furthermore, FOXA2 is required for proper chromatin remodeling and H3K4me1 deposition during enhancer priming. This work highlights the power of combining hPSC differentiation, genome editing, and computational genomics for discovering transcriptional mechanisms during development. : Lee et al. use ATAC-seq to identify key transcriptional factors involved in human pancreatic differentiation. FOXA2 knockout human pluripotent stem cells showed impaired differentiation to pancreatic progenitors, a phenotype not observed in Foxa2 conditional knockout mice. Furthermore, FOXA2 is required for proper chromatin remodeling and H3K4me1 deposition during enhancer priming. Keywords: human pluripotent stem cells, hPSCs, human embryonic stem cells, hESCs, pancreatic progenitors, ATAC-seq and chromatin accessibility, FOXA2, FOXA1, enhancer priming and activation, nucleosome remodeling, PDX1, GATA6http://www.sciencedirect.com/science/article/pii/S2211124719308009
spellingShingle Kihyun Lee
Hyunwoo Cho
Robert W. Rickert
Qing V. Li
Julian Pulecio
Christina S. Leslie
Danwei Huangfu
FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
Cell Reports
title FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
title_full FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
title_fullStr FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
title_full_unstemmed FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
title_short FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
title_sort foxa2 is required for enhancer priming during pancreatic differentiation
url http://www.sciencedirect.com/science/article/pii/S2211124719308009
work_keys_str_mv AT kihyunlee foxa2isrequiredforenhancerprimingduringpancreaticdifferentiation
AT hyunwoocho foxa2isrequiredforenhancerprimingduringpancreaticdifferentiation
AT robertwrickert foxa2isrequiredforenhancerprimingduringpancreaticdifferentiation
AT qingvli foxa2isrequiredforenhancerprimingduringpancreaticdifferentiation
AT julianpulecio foxa2isrequiredforenhancerprimingduringpancreaticdifferentiation
AT christinasleslie foxa2isrequiredforenhancerprimingduringpancreaticdifferentiation
AT danweihuangfu foxa2isrequiredforenhancerprimingduringpancreaticdifferentiation